Full text
PDF






Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- COLOMBO J. P., RICHTERICH R., ROSSI E. [Serum creatine phosphokinase: determination and diagnostic significance]. Klin Wochenschr. 1962 Jan 1;40:37–44. doi: 10.1007/BF01483449. [DOI] [PubMed] [Google Scholar]
- DREYFUS J. C., SCHAPIRA G., RESNAIS J., SCEBAT L. [Serum creatine kinase in the diagnosis of myocardial infarct]. Rev Fr Etud Clin Biol. 1960 Apr;5:386–387. [PubMed] [Google Scholar]
- DRIVSHOLM A., MADSEN S. The influence of treatment with sodium salicylate on the serum glutamic oxalacetic transaminase activity. Scand J Clin Lab Invest. 1961;13:442–446. [PubMed] [Google Scholar]
- ELLIOTT B. A., WILKINSON J. H. Serum "alpha-hydroxybutyric dehydrogenase" in myocardial infarction and in liver disease. Lancet. 1961 Apr 1;1(7179):698–699. doi: 10.1016/s0140-6736(61)91724-x. [DOI] [PubMed] [Google Scholar]
- FORSTER G., ESCHER J. [Creatine phosphokinase in the diagnosis of myocardial infarction and myopathies]. Helv Med Acta. 1961 Sep;28:513–519. [PubMed] [Google Scholar]
- HENLEY K. S., POLLARD H. M. A new method for the determination of glutamic oxalacetic and glutamic pyruvic transaminase in plasma. J Lab Clin Med. 1955 Nov;46(5):785–789. [PubMed] [Google Scholar]
- HUGHES B. P. A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin Chim Acta. 1962 Sep;7:597–603. doi: 10.1016/0009-8981(62)90137-7. [DOI] [PubMed] [Google Scholar]
- KONTTINEN A., HALONEN P. I. Serum alpha-hydroxybutyric dehydrogenase (HBD) in myocardial infarction. Comparison with glutamic oxalacetic transminase (GOT) and lactic dehydrogenase (LDH). Am J Cardiol. 1962 Oct;10:525–531. doi: 10.1016/0002-9149(62)90377-6. [DOI] [PubMed] [Google Scholar]
- LADUE J. S., WROBLEWSKI F., KARMEN A. Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction. Science. 1954 Sep 24;120(3117):497–499. doi: 10.1126/science.120.3117.497. [DOI] [PubMed] [Google Scholar]
- MOLLER C. E., RAABO E. DIAGNOSTIC USE OF FRACTIONATED LACTIC DEHYDROGENASE ACTIVITY (LDH) IN MYOCARDIAL INFARCTION. Acta Med Scand. 1964 Jan;175:31–42. doi: 10.1111/j.0954-6820.1964.tb00547.x. [DOI] [PubMed] [Google Scholar]
- PAGLIARO L., NOTARBARTOLO A. Alpha-Hydroxybutyric dehydrogenase in the diagnosis of myocardial infarction. Lancet. 1962 May 19;1(7238):1043–1045. doi: 10.1016/s0140-6736(62)92144-x. [DOI] [PubMed] [Google Scholar]
- ROSALKI S. B., WILKINSON J. H. Reduction of alpha-ketobutyrate by human serum. Nature. 1960 Dec 24;188:1110–1111. doi: 10.1038/1881110a0. [DOI] [PubMed] [Google Scholar]
- SCEBAT L., RENAIS J., LENEGRE J. [Serum creatine-kinase in the diagnosis of myocardial lesions. (Clinical and experimental study)]. Arch Mal Coeur Vaiss. 1961 Jul;54:721–731. [PubMed] [Google Scholar]
- SCHNEIDER K. W., HEISE E. R. [Diagnostic significance of increased creatine phosphokinase activity in the blood]. Dtsch Med Wochenschr. 1963 Mar 15;88:520–525. doi: 10.1055/s-0028-1111974. [DOI] [PubMed] [Google Scholar]
- SORENSEN N. S. CREATINE PHOSPHOKINASE IN THE DIAGNOSIS OF MYOCARDIAL INFARCTION. Acta Med Scand. 1963 Dec;174:725–734. [PubMed] [Google Scholar]
- TANZER M. L., GILVARG C. Creatine and creatine kinase measurement. J Biol Chem. 1959 Dec;234:3201–3204. [PubMed] [Google Scholar]
- WROBLEWSKI F., LADUE J. S. Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med. 1955 Oct;90(1):210–213. doi: 10.3181/00379727-90-21985. [DOI] [PubMed] [Google Scholar]
